Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. (2016)

First Author: Arabi YM
Attributed to:  International Severe Acute Respiratory and Emerging Infections Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3201/eid2209.151164

PubMed Identifier: 27532807

Publication URI: http://europepmc.org/abstract/MED/27532807

Type: Journal Article/Review

Volume: 22

Parent Publication: Emerging infectious diseases

Issue: 9

ISSN: 1080-6040